VIDEO: Neil Riordan, PA, PhD discusses Stem Cells: Their Role in Aging and in the Treatment of Chronic Diseases

At our May 4th 2019 event in Southlake, Texas, Dr. Riordan discusses stem cell therapy at the Stem Cell Institute in Panama City, Panama. He mentions the two main types of adult stem cells but his talk focuses on mesenchymal stem cells including their sources and functions. Then he goes on to discuss specifically the specially selected human umbilical cord tissue-derived MSCs used in Panama. He highlights several clinical trials for spinal cord injury, rheumatoid arthritis, diabetes and cancer inhibition. He shows MSCs growing in culture and discusses 3D culturing. He then goes into cord tissue products being offered in the US including Signature Cord, a minimally-manipulated Wharton’s jelly product he developed. Finally, Dr. Riordan discusses current US law and the new stem cell law in Texas, including where he sees the industry in the US going from here.

Neil Riordan, PA, PhD Presents at the 5th Annual Perinatal Stem Cell Society Congress in Salt Lake City, UT on Thursday, February 28th

Neil Riordan, PA, PhD presented “Results From Panama Clinical Trials Using Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells (HUCT-MSCs) for Multiple Sclerosis and Autism” at the 5th Annual Perinatal Stem Cell Society Congress in Salt Lake City, UT on Thursday, February 28th.

Image of Neil Riordan, PA, PhD

Neil Riordan, PA, PhD

SALT LAKE CITY (PRWEB) MARCH 01, 2019

Neil Riordan, PA, PhD presented “Results From Panama Clinical Trials Using Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells (HUCT-MSCs) for Multiple Sclerosis and Autism” at the 5th Annual Perinatal Stem Cell Society Congress in Salt Lake City, UT on Thursday, February 28t.

During his talk, Dr. Riordan discussed his recently published phase I/II clinical trial entitled, “Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosis”.

“It was an honor to speak with my distinguished peers on the advances of stem cell therapy in perinatal medicine today,” Neil H. Riordan, PA, PhD

https://www.ncbi.nlm.nih.gov/pubmed/29523171

He also touched on his recently completed and soon-to-be-published phase 1/II clinical trial on autism, “Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy for Autism” (NCT02192749).

About Perinatal Stem Cell Society

In 2013, the International Perinatal Stem Cell Society, Inc. a non-profit (501(c)(3) organization was founded on the basic principle that stem cells from perinatal tissues contain enormous, untapped life potential to treat many diseases and disorders. Perinatal stem cell sources include: amnion, amniotic fluid, cord blood, cord tissue/wharton’s jelly, as well as placental blood and placental tissue. Perinatal stem cells are formed around the time of birth and are classified as adult stem cells but they really are more primitive then stem cells found in bone marrow or adipose tissue or other traditional sources of adult stem cells and as such, have greater therapeutic potential.

Learn more at http://www.perinatalstemcells.com

About Riordan Technologies

Riordan Technologies strives to improve the human condition through innovation in scientific research, regenerative medicine, and stem cell therapy. Riordan Technologies comprises companies founded by Neil Riordan, PA, PhD: Dallas-based Aidan Products, Signature Biologics, and Riordan Medical Institute, and Panama-based Stem Cell Institute and Medistem Panama.

Read Dr. Riordan’s Amazon #1 Best Seller: Stem Cell Therapy: A Rising Tide – How Stem Cells Are Disrupting Medicine and Transforming Lives

Learn more at at http://www.neilriordan.com

Multiple Sclerosis News Today: Stem Cell Institute MS Trial is #4 in Top 10 MS Stories of 2018

Image of Top 10 Banner

Congratulations to Dr. Riordan and everyone at Stem Cell Institute and Medistem Labs in Panama!

Multiple Sclerosis News Today published its Top 10 Multiple Sclerosis Stories of 2018 and named Stem Cell Institute’s MS clinical trial its #4 top MS story of 2018.

The name of the article that reached #4 is “Treatment with Umbilical Cord Stem Cells Safe with Sustained Benefits for MS, Trial Shows”

The original peer-reviewed article, entitled “Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosis” is published in the Journal of Translational Medicine and can be viewed here:  https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-018-1433-7

Regenerative Medicine Center Opens at Southwest College of Naturopathic Medicine and Health Sciences

The Neil Riordan Center for Regenerative Medicine Focuses on Non-Opioid Treatments of Pain

(Tempe, Arizona, October 2, 2018)–Southwest College of Naturopathic Medicine & Health Sciences team will cut the ribbon for the opening of the new Neil Riordan Center for Regenerative Medicine on November 15 at 4:00 p.m. This affiliation between SCNM and Neil H. Riordan, PA, PhD, a research leader in stem cell therapy, will accelerate the development of this safe and innovative option for the treatment of acute and chronic pain. The Neil Riordan Center for Regenerative Medicine is staffed by an interdisciplinary team of physicians, and housed in SCNM’s LEED Platinum certified Community Commons.

Regenerative medicine, particularly autologous stem cell therapy, utilizes a patient’s own stem cells to promote healing, reduce inflammation and stimulate tissue repair. People with acute and chronic pain, including elite athletes, may benefit from the growth factors, natural anti-inflammatory activity, and regenerative properties of autologous stem cell therapy.

Over 100 million Americans suffer from chronic pain at an annual cost estimated at exceeding $620 billion, the many of whom are currently treated using opioids. This has led to wide-spread abuse and addiction to prescription opioids and illicit drugs including heroin. Opioid addiction and abuse has been attributed to 37,000 deaths each year nationally and 1,763 deaths of Arizonans from opioid overdoses in the past fifteen months. Stem cell therapy promises to limit the reliance on opioids thereby decreasing the potential for opioid addiction and abuse.

Neil Riordan, PA, PhD, is a pioneer in the field of applied stem cell research. In addition to collaboration with major universities in the United States, research and patient care is currently being conducted at Dr. Riordan’s other laboratories and clinics in Dallas, Texas and Panama City, Panama. He is an author on more than seventy peer-reviewed research publications, including clinical studies that explore stem cell therapy’s potential in treating conditions such as autism, multiple sclerosis, and rheumatoid arthritis.

Dr. Riordan is the author of two books on stem cell therapy: Stem Cell Therapy: A Rising Tide – How Stem Cells are Disrupting Medicine and Changing Lives and MSC (Mesenchymal Stem Cells): Clinical Evidence Leading Medicine’s Next Frontier.

We welcome any questions or comments. Please contact Kirsten Texler at k.texler@scnm.edu for more information.

Image of Southwest College of Naturopathic Medicine Logo and Tag Line

A leader in inspiring, teaching and providing multiple modalities in the scope of naturopathic medicine, Southwest College of Naturopathic Medicine not only educates but also elevates society’s awareness of the power of holistic medicine. Campus highlights include a fully accredited four-year naturopathic doctoral program, a robust medical clinic open to the public, a dedicated pain relief and regenerative medicine center, innovative and inspirational public events, an on-site medicinary and multiple opportunities for ground-breaking research. Additionally, the SCNM Sage Foundation highlights the focus on philanthropy instilled in students and faculty as they provide care for underserved communities in seven satellite locations. Southwest College of Naturopathic Medicine is dedicated to the idea that every person deserves high-quality fully integrated healthcare and creates an impact on the world through providing a private non-profit education in the culturally rich state of Arizona.

Acclaimed Guitarist Sonny Mayo on Stem Cell Therapy in Panama

From:  The EXPLODING HUMAN with Bob Nickman

Image of Sonny Mayo

SONNY MAYO, former guitarist for bands like Ugly Kid Joe and Snot, talks to me about getting STEM CELL THERAPY in Panama for a genetic heart condition. After two heart attacks and unpleasant side-effects from heart medications, Sonny was introduced to stem cell therapy through listening to a Joe Rogan podcast.  Raising money through GoFundMe, he was able too make the trip and receive treatment which is not yet legal in the United States.  Sonny is a stellar example of taking back his health treatment from an often limited and close-minded medical  system.  This is an important message as heart disease is the #1 killer in our country!

Original Link: http://theexplodinghuman.libsyn.com/episode-23-sonny-mayo-stem-cell-healing

For more information about stem cell therapy for heart disease, please visit: https://www.cellmedicine.com/stem-cell-therapy-for-heart-failure/

Stem Cell Therapy in Panama Motivates Tony Robbins, NY Times #1 Best-selling Author!

Image of Motivational Speaker Tony Robbins at Stem Cell Institute in Panama

“Feeling absolutely invigorated after our trip to Panama this weekend, where I received the transformative benefits of stem cell therapy! Our huge thanks and honor to all the doctors and the bright, caring medical staff at the state-of-the-art Stem Cell Institute in Panama City, Panama 🇵🇦. Stem cells saved my shoulder after struggling with excruciating pain from spinal stenosis and, more recently, a torn rotator cuff. Stem cell treatment is truly a next-level health innovation that can reverse the wear and tear we put on our bodies and prevent debilitating disease and injury from escalating further 🔬. This technological advancement will impact humanity in life-changing ways— it has the potential to transform and save MILLIONS of lives!…”  View Original Instagram Post
.

Read Dr. Riordan’s Amazon #1 best-selling book about stem cell therapy today

“Neil takes readers on a riveting journey through the past, present and future of stem cell therapy. His well-researched, educational and entertaining book could change your life. I highly recommend it.”Tony Robbins, NY Times #1 Bestselling Author 

Image of Stem Cell Therapy - A Rising Tide Book Cover

Stem cells are the repair cells of your body. When there aren’t enough of them, or they aren’t working properly, chronic diseases can manifest and persist.

Neil H Riordan, PA, PhD, author of MSC: Clinical Evidence Leading Medicine’s Next Frontier, the definitive textbook on clinical stem cell therapy, brings you an easy-to-read book about how and why stem cells work, and why they’re the wave of the future.

From industry leaders, sport stars, and Hollywood icons to thousands of everyday, ordinary people, stem cell therapy has helped when standard medicine failed. Many of them had lost hope. These are their stories.

Purchase

Multiple Sclerosis News Today Covers Stem Cell Institute Clinical Trial for MS

Image of GMP syringe prep lab at Stem Cell Institute clinic in Panama.

Stem cells being prepared for treatment.

Multiple Sclerosis News Today has published an article entitled “Treatment with Umbilical Cord Stem Cells Safe with Sustained Benefits for MS, Trial Shows“. This article can be read in its entirely at MultipleSclerosisNewsToday.com.

The name of the study, which is published in the Journal of Translational Medicine, is “Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosis”.

The study concluded that “…intravenous infusion of UCMSC over several days is safe in subjects with MS. Additionally, UCMSC infusions may hold benefits, since this small study group saw improvement in bladder, bowel, and sexual dysfunction, walking, upper extremity physical function, energy and fatigue, general perspective of a positive health change and improved quality of life, and MRI lesions. More clinical studies, particularly with a larger cohort, are needed to substantiate the specific benefits of UCMSC infusion as a potential MS therapy.”

Podcast: Listen to Dr. Mike Hutchinson, DVM interview with Dr. Riordan about stem cell therapy

About This Episode

Delve deeper into the stem cell world with pioneer and expert Dr. Neil Riordan. Co-founder/chief science officer of the Riordan-McKenna Institute, founder/chairman/chief science officer of the Stem Cell Institute and author of Stem Cell Therapy: A Rising Tide, he’s here to discuss ongoing stem cell studies with Duchenne Muscular Dystrophy, spinal cord injuries, MS, autism and more. He’ll also answer one of the most common stem cell questions: how can one cell treat so many different conditions?

View on drmikehutchinson.com

Stem Cell Therapy for Heart Failure – Anita Ciszewski’s Story

The heart attack I had at 44 was a massive one – a 3 on a scale of 4, so the damage was very bad. When you get a 3, you know at 4 you’re dead. The whole left side was damaged, and it was the hospital’s fault because back then when a woman went in with chest pain they didn’t care 20 years ago. If I’d been a man they’d have paid more attention but because I was young, they left me for six hours and did nothing. During those six hours, I was in full-blown heart attack mode and imagine the damage that was done. The nurses kept saying it but nobody else noticed. The waiting list in Canada for the bypass was a year and a half and that’s how we ended up in Miami with Dr. Kretchmar. He is the doctor I trust. He’s been with me for 20 years. I felt good after my bypass for about ten years and then I started going downhill, started getting blockages again. I’ve got three stents implanted not to mention a torn artery. That’s when Dr. Kretchmar recommended that I go to Panama for stem cells.

So, I got on a plane with my son and went for the treatment at the Stem Cell Institute. I went back six months later, not because I had to, because I wanted to, I didn’t want to take any chances of any fall back. I wanted to be on the safe side. I went the second time and the side effects weren’t that bad, there were hardly any side effects.

I found the second treatment was even better than the first. I was getting more energy, I was doing things . . . I could kneel down and pick something up and get up again, but I noticed in the summertime working around the pool that I was able to pick up leaves, vacuum the pool, and doing things that I haven’t done in a couple of years.

I decided again on my own that I was going back again. I went again the third time and I’ve been going every six months. After the third one, I realized I didn’t need nitro anymore. I wasn’t using the nitro patch, nor was I using the nitroglycerin spray. I had no angina. I was shocked. I couldn’t believe it. Before, I couldn’t go up a flight of stairs without stopping halfway!

Thing were progressing so well that I said, can I come back again? I just wanted this to keep going that way. I did have a fourth treatment in October. After the fourth treatment, we decided that we’ll wait a year because four is quite a bit, and I’m feeling . . . as long as I feel like I’m doing great, there’s no point in me just going for the sake of going. It’s all good

I used to get up and fall asleep all over the place. I’d get up in the morning, grab a cup of coffee, and then I was sleeping with my coffee in my hands. I didn’t even know I was sleeping. I would take my granddaughter to see a movie and she’d be waking me up after the movie was over. I just could not stay awake. I felt so weak; zero energy, none whatsoever. I’ve seen a huge, huge difference. I’ve mentioned it to so many people that know me already. I say, “listen guys, I’ve gone there four times, had four treatments, and I’ll go back again if I have to.” For me that was my saving grace.

High-Dose Intravenous Vitamin C Therapy at Riordan Clinic Offers New Hope to Young Cancer Patient After Chemotherapy Fails

WICHITA, KANSAS (PRWEB) NOVEMBER 15, 2016

Hoyt Lee

Hoyt Lee

After undergoing failed chemotherapy treatments and the debilitating side effects that go along with them, things are finally looking up for 6 year-old cancer patient, Hoyt Lee. Since starting high-dose intravenous vitamin C therapy at the Riordan Clinic in Wichita, Kansas two and a half years ago, Hoyt’s condition stabilized and is now improving; something his oncologists said would likely never happen.

At just three months of age, doctors diagnosed Hoyt Lee with Neurofibromatosis 1 (NF-1). At 16 months old, he started chemotherapy for a brain tumor. After completing a grueling year of drug cocktails that wracked his young body, Hoyt’s mother, Shawna Overbey, received the news that she’d feared the most. Hoyt’s tumors were not responding to the chemo. They were growing.
Magnetic Resonance Imaging (MRI) showed accelerated tumor growth in his optic nerve chiasm. The optic chiasm is an X-shaped structure formed by the crossing of the optic nerves in the brain. The tumor was affecting his right and left eyes, his pituitary gland, and his hypothalamus.

The only available treatment alternatives were radiation or a different chemotherapy cocktail that can cause nerve damage and affect motor skills like walking and hand movement.

That’s when Shawna knew there had to be another way. Countless hours of research lead Shawna and Hoyt to Dr. Ron Hunninghake at the Riordan Clinic, a non-profit organization in Wichita, Kansas that specializes in alternative cancer therapies. The Riordan Clinic was founded in 1975 by Dr. Hugh Riordan and benefactor Olive W. Garvey. It has been providing IV therapy to patients like Hoyt for the past 40 years.

The late Dr. Riordan and his son, Neil H. Riordan, PhD, were pioneers in the use of vitamin C to treat cancer. Far ahead of their time, they invented patents (6,448,287, 6,436,411, 6,284,786) on treating cancer with vitamin C that date back prior to the turn of this century. For the past 20 years, Nina Mikirova, PhD has carried on their cancer research at the clinic.

At present, Neil Riordan, PhD is a renowned applied stem cell therapy researcher whose clinic in Panama, Stem Cell Institute, specializes in treating inflammatory and autoimmune related conditions with human *umbilical cord tissue–derived mesenchymal stem cells. Dr. Riordan has also teamed up with board-certified orthopedic surgeon, Wade McKenna, DO to bring stem cell therapy for orthopedic conditions to Southlake, Texas at the Riordan-McKenna Institute (RMI). RMI uses a proprietary mixture of the patient’s own bone marrow stem cells with *amniotic tissue products. Patients can receive intravenous high-dose vitamin C and other intravenous nutritional supplements at Riordan Wellness, which occupies space at the RMI building in Southlake.

Decades after the Riordans’ pioneering research, ascorbic acid treatment for cancer is entering the mainstream, with clinical trials being conducted at John’s Hopkins, University of Iowa, Jefferson University and Cornell. A clinical trial on vitamin C and prostate cancer was recently completed at Copenhagen University Hospital at Herlev, Denmark and in a study published November 5th in Science, a team of researchers from Weill Cornell Medicine, Cold Spring Harbor Laboratory, Tufts Medical Center, Harvard Medical School and The Johns Hopkins Kimmel Cancer Center found that high doses of vitamin C – roughly equivalent to the levels found in 300 oranges – impaired the growth of KRAS mutant and BRAF mutant colorectal tumors in cultured cells and mice.

Since undergoing IV high-dose vitamin C therapy, Hoyt Lee’s progress has been miraculous. According to his mother, MRIs have shown tumor stability or shrinkage over the past two and a half years. The tumor is no longer affecting his right eye, pituitary gland or hypothalamus. As of February 2016, there is almost no sign of a tumor in Hoyt’s optic nerve chiasm. Hoyt is doing so well that he won’t have to return to the hospital for another year.

“As Schopenhauer said, ‘All truth passes through three stages. First, it is ridiculed. Second, it is violently opposed. Third, it is accepted as being self-evident.’,” said Dr. Riordan. “As far as high-dose vitamin C goes, I think that, fortunately, we are finally entering the third stage,’ he added.

“We are delighted with Hoyt’s progress and equally proud that through generous charitable contributions, we’ve been able to do it without the crushing costs that can be associated with conventional treatments like chemotherapy,” commented Donna Kramme, CEO of Riordan Clinic. “It can cost as much as $15,000 per year to treat a child like Hoyt. We ask that everyone who is passionate about helping children like Hoyt please contact the Riordan Clinic to donate today. Without your help we cannot continue vital research that will make Hugh Riordan’s dream four decades ago, a reality today and into the future,” she concluded.

About Riordan Clinic

Riordan Clinic is a not-for-profit 501(c)(3), nutrition-based health facility in Wichita, Kansas. We have integrated lifestyle and nutrition to help you find the underlying causes of your illness. Since our inception in 1975, our mission has been clear and unwavering. Our functional medicine providers “stimulate an epidemic of health.”

People turn to the Riordan Clinic to restore, improve, and maintain health. Our integrative health practitioners listen to the needs of patients. Then we test and measure to map out a research-based, nutrition-fueled path to well being. Together, our professionals move beyond simply treating symptoms to address illness at its cause. Your Way to Well communicates a positive, hope-filled message. It stresses our individualized approach and achieves the best possible outcomes.

Riordan Clinic Website: http://www.riordanclinic.org

Riordan Clinic
3100 N. Hillside Ave.
Wichita, Kansas
67219

Tel: (316) 682-3100
Fax: (316) 682-2062

About Riordan-McKenna Institute (RMI)

RMI specializes in non-surgical treatment of acute and chronic orthopedic conditions using *amniotic tissue allograft and bone marrow aspirate concentrate (BMAC) that is harvested using the patented BioMAC bone marrow aspiration cannula. Common conditions treated include meniscal tears, ACL injuries, rotator cuff injuries, runner’s knee, tennis elbow, and joint pain due to degenerative conditions like osteoarthritis.

Additionally, RMI augments orthopedic surgeries with BMAC and amniotic tissue allograft to promote better post-surgical outcomes and uses amniotic membranes as part of a complete wound care treatment regimen.

BMAC contains a patient’s own mesenchymal stem cells (MSC,) hematopoietic stem cells (CD34+), growth factors and other progenitor cells. Amniotic tissue allograft is composed of collagens and other structural proteins, which provide a biologic matrix that supports angiogenesis, tissue growth and new collagen during tissue regeneration and repair.
*Amniotic tissue is donated after normal healthy births.

Riordan-McKenna Institute Website: http://www.rmiclinic.com

Riordan-McKenna Institute
801 E. Southlake Blvd.
Southlake, Texas
76092

Tel: (817) 776-8155
Toll Free: (877) 899-7836
Fax: (817) 776-8154

About Stem Cell Institute Panama

Founded in 2007 on the principles of providing unbiased, scientifically sound treatment options; the Stem Cell Institute (SCI) has matured into the world’s leading adult stem cell therapy and research center. In close collaboration with universities and physicians world-wide, our comprehensive stem cell treatment protocols employ well-targeted combinations of autologous bone marrow stem cells, autologous adipose stem cells, and donor human umbilical cord stem cells to treat: autism, cerebral palsy, multiple sclerosis, spinal cord injury, osteoarthritis, rheumatoid arthritis, heart disease, and autoimmune diseases.

In partnership with Translational Biosciences, a subsidiary of Medistem Panama, SCI provides clinical services for ongoing clinical trials that are assessing safety and signs of efficacy for autism, multiple sclerosis, osteoarthritis, rheumatoid arthritis, and spinal cord injury using allogeneic umbilical cord tissue-derived mesenchymal stem cells (hUC-MSC) and hU-MSC-derived mesenchymal trophic factors (MTF). In 2017, Translation Biosciences plans to expand its clinical trial portfolio to include heart disease and cerebral palsy.

For more information on stem cell therapy:

Stem Cell Institute Website: https://www.cellmedicine.com

Aquilino de la Guardia Street
BICSA Financial Center
63rd Floor
Panama City, Panama

*Tissue is donated after normal, healthy births.